Comparison between genetic and pharmaceutical disruption of Ldlr expression for the development of atherosclerosis is a research paper published in Journal of Lipid Research (2022). On theSindex it has a DataRank of 0. It has been cited 8 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Diabetes Research Center, University of Washington
Grant: P30 DK017047
National Institute of Food and Agriculture
Grant: 2019-07916
National Heart, Lung, and Blood Institute
Grant: P01 HL151328
National Heart, Lung, and Blood Institute
Grant: P01 HL092969
National Heart, Lung, and Blood Institute
Grant: R35 HL150754
National Institutes of Health
Grant: K01 AT007177
National Institutes of Health
Grant: 5R35HL150754-02
Identifying new strategies for prevention of cardiovascular complications of diabetes
National Institutes of Health
Grant: 1P01HL151328-01
Triglycerides, Diabetes and Cardiovascular Disease
National Institutes of Health
Grant: 5P01HL092969-55
Cardiovascular Disease and Diabetes Program Project
National Institutes of Health
Grant: 5K01AT007177-05
Alterations in Adipocyte Lipid Metabolism by Trans-10, Cis-12 CLA Supplementation
National Institutes of Health
Grant: 2P30DK017047-42
Diabetes Research Center
Fields of Study
Keywords